Citralka dose for male with uti
Reading File
Searching for Citralka dosing and UTI management in males.
search_medical_text
Citralka sodium citrate dosing UTI urinary tract infection
search_medical_text
urinary tract infection male management treatment dose
Treatment of Extended Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTRP. aeruginosa)
Page 2
GradeResponse
GradeResponse
No direct database results for Citralka specifically. Here is a comprehensive answer based on established pharmacology and clinical guidelines:
Citralka (Disodium Hydrogen Citrate) for UTI in Males
What is Citralka?
Citralka contains disodium hydrogen citrate as the active ingredient. It is a urinary alkalinizer — it raises urinary pH, which relieves the burning/dysuria associated with UTIs and makes the urine hostile to bacterial growth (many uropathogens prefer acidic urine).
Important: Citralka is a symptomatic/adjunct treatment. It does not replace antibiotics, especially in males where UTI is classified as a complicated UTI (due to anatomical factors).
Standard Dose
| Parameter | Details |
|---|---|
| Drug | Disodium hydrogen citrate (Citralka syrup) |
| Standard dose | 10 mL (1.4 g disodium hydrogen citrate) three times daily |
| Timing | After meals, diluted in a full glass of water |
| Duration | Typically 3–7 days for symptomatic relief |
Dosing in Males with UTI
- The dose is the same as in females: 10 mL TDS (three times a day) with plenty of water.
- Males should always be co-prescribed an appropriate antibiotic because UTI in males is considered complicated and is more likely to involve the prostate (prostatitis) or upper tract (pyelonephritis).
- Citralka alone is insufficient treatment — it only addresses dysuria and acidic urine discomfort.
How to Take
- Measure 10 mL of Citralka syrup.
- Dilute in a full glass of water (150–200 mL).
- Take after meals, 3 times daily.
- Drink plenty of fluids throughout the day (>2 L/day) to help flush bacteria.
Contraindications / Cautions
- Renal impairment (sodium load and citrate accumulation risk)
- Hypertension / sodium-restricted diet (each dose contains sodium)
- Metabolic alkalosis
- Hyperkalemia (if potassium citrate formulation is used)
- Heart failure (sodium load)
Key Clinical Note for Males
UTI in any adult male is, by definition, a complicated UTI per infectious disease guidelines. Always evaluate for:
- Prostatitis (most common cause of recurrent UTI in men)
- Urethral stricture or BPH
- Indwelling catheter
- Renal calculi
Antibiotic choices typically include fluoroquinolones (ciprofloxacin, levofloxacin) or trimethoprim-sulfamethoxazole for 7–14 days, guided by urine culture and sensitivity results.
Bottom line: Citralka 10 mL TDS after food with plenty of water, as an adjunct to appropriate antibiotic therapy. The antibiotic is non-negotiable in a male with UTI.
UTI treatment can para be given in decompensated chronic liver disease patient
search_medical_text
paracetamol safety decompensated chronic liver disease
Prescribing Drugs of Dependence in General Practice - Opioids
Page 81
search_medical_text
UTI antibiotic treatment chronic liver disease cirrhosis
Complicated Urinary Tract Infections in Children
Page 7
GradeResponse
GradeResponse
search_medical_text
paracetamol hepatotoxicity cirrhosis decompensated liver NAPQI glutathione
search_medical_text
analgesic antipyretic dose reduction liver failure hepatic impairment
Paracetamol (Para) in Decompensated Chronic Liver Disease (CLD) — for UTI
Short Answer
Yes, paracetamol CAN be used, but at a reduced dose and with caution. It is actually the preferred analgesic/antipyretic in liver disease patients — NSAIDs and opioids carry greater risks.
Paracetamol Safety in Liver Disease
| Condition | Recommendation |
|---|---|
| Compensated CLD | Standard dose acceptable; max 4 g/day |
| Decompensated CLD (cirrhosis with ascites, encephalopathy, jaundice, coagulopathy) | Reduced dose: 2–3 g/day in divided doses (per guidelines) |
| Active alcohol use / malnourished | Use with caution; glutathione stores depleted — lower threshold for toxicity |
| Acute liver failure | Avoid |
Per "Prescribing Drugs of Dependence in General Practice - Opioids" (p. 81): "Paracetamol is safe in patients with chronic liver disease, but a reduced dose of 2–3 g daily is recommended for long-term use."
Why the Concern?
- Paracetamol is metabolized via glucuronidation and sulfation (safe pathways), with a small fraction via CYP2E1 → NAPQI (toxic metabolite).
- NAPQI is neutralized by glutathione, which is depleted in decompensated liver disease and malnutrition.
- At normal doses in a decompensated liver, the NAPQI pathway becomes relatively more active → risk of hepatotoxicity increases.
Practical Dosing in Decompensated CLD with UTI
| Parameter | Guidance |
|---|---|
| Dose | 500 mg every 8 hours (1.5 g/day) — conservative approach |
| Maximum | Do not exceed 2 g/day in decompensated disease |
| Frequency | TDS or BD (not QDS) |
| Duration | Shortest effective duration |
| Avoid | Fasting state, concurrent alcohol, hepatotoxic drugs |
What to Avoid in Decompensated CLD
| Drug | Reason to Avoid |
|---|---|
| NSAIDs (ibuprofen, diclofenac) | Renal vasoconstriction → precipitates hepatorenal syndrome, worsen ascites, GI bleed risk |
| Opioids | Precipitate hepatic encephalopathy |
| Aspirin | GI bleed risk, antiplatelet effect worsens coagulopathy |
Paracetamol at reduced dose remains safer than all alternatives for fever/pain in this population.
UTI Antibiotic Choice in Decompensated CLD
For the UTI itself, antibiotic selection should account for hepatic metabolism:
- Nitrofurantoin — avoid (risk of hepatotoxicity, also avoid if GFR <45)
- Ciprofloxacin — use with caution (partial hepatic metabolism); reduce dose if severe impairment
- Trimethoprim-sulfamethoxazole — avoid in severe liver disease (sulfonamide hepatotoxicity risk)
- Cephalexin / Cefuroxime — generally safe (primarily renal excretion); preferred option
- Amoxicillin-clavulanate — avoid (cholestatic hepatitis risk)
Preferred antibiotic for UTI in decompensated CLD: Cephalexin 500 mg TDS × 7–14 days, guided by urine culture and sensitivity.
Bottom Line
- Paracetamol: Yes, give it — but cap at 1.5–2 g/day in decompensated CLD.
- Always use the lowest effective dose for the shortest duration.
- Monitor LFTs if prolonged use is anticipated.
- Ensure the patient is not malnourished or actively drinking alcohol.
This is a shared conversation. Sign in to Orris to start your own chat.